Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Prepaid Assets (2017 - 2025)

Protagonist Therapeutics' Prepaid Assets history spans 9 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 63.48% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, up 63.48%, while the annual FY2025 figure was $1.1 million, 63.48% up from the prior year.
  • Prepaid Assets for Q4 2025 was $1.1 million at Protagonist Therapeutics, up from $174000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $9.7 million in Q2 2022 and bottomed at $174000.0 in Q3 2025.
  • The 5-year median for Prepaid Assets is $2.9 million (2021), against an average of $4.1 million.
  • The largest annual shift saw Prepaid Assets surged 227.15% in 2022 before it tumbled 97.84% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $1.7 million in 2021, then soared by 227.15% to $5.7 million in 2022, then crashed by 30.67% to $4.0 million in 2023, then crashed by 83.61% to $649000.0 in 2024, then skyrocketed by 63.48% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PTGX's Prepaid Assets are $1.1 million (Q4 2025), $174000.0 (Q3 2025), and $884000.0 (Q2 2025).